Maltodextrin-Nanoparticles as a Delivery System for Nasal Vaccines: A Review Article - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Pharmaceutics Année : 2024

Maltodextrin-Nanoparticles as a Delivery System for Nasal Vaccines: A Review Article

Résumé

Nanoparticles are increasingly being studied as antigen delivery systems for immunization with nasal vaccines. The addition of adjuvants is still generally required in many nanoparticle formulations, which can induce potential side effects owing to mucosal reactogenicity. In contrast, maltodextrin nanoparticles do not require additional immunomodulators, and have been shown to be efficient vaccine delivery systems. In this review, the development of maltodextrin nanoparticles is presented, specifically their physico-chemical properties, their ability to load antigens and deliver them into airway mucosal cells, and the extent to which they trigger protective immune responses against bacterial, viral, and parasitic infections. We demonstrate that the addition of lipids to maltodextrin nanoparticles increases their potency as a vaccine delivery system for nasal administration.
Fichier principal
Vignette du fichier
Fasquelle et al 2024 - Maltodextrin-nanoparticles as a delivery system for nasal vaccines - a review.pdf (2.19 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04453094 , version 1 (12-02-2024)

Identifiants

Citer

François Fasquelle, Angelo Scuotto, Michael Howsam, Didier Betbeder. Maltodextrin-Nanoparticles as a Delivery System for Nasal Vaccines: A Review Article. Pharmaceutics, 2024, 16, ⟨10.3390/pharmaceutics16020247⟩. ⟨hal-04453094⟩
8 Consultations
8 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More